The pharmacovigilance market size is estimated to be USD 6,590.8 million in 2022 and is expected to witness a CAGR of 11.84% during the forecast period 2023-2033. The rising quantity of ADRs and associated consumer hazards, the growing elderly population, and increased usage of drugs globally as chronic illnesses including diabetes, cardiovascular, oncological, and respiratory ailments are factors contributing to the market growth. However, internet-based medicine information and the lack of available competent personnel are expected to hinder the growth.
Segmentation
By Type
On the basis of type, the market is categorized into intensified ADR reporting, spontaneous reporting, EHR mining, cohort event monitoring, and targeted spontaneous reporting. In the global market, the targeted spontaneous reporting segment accounted for the largest revenue share in 2022 owing to the widely used technique for the quick and low-cost identification of novel, severe, and uncommon ADRs.
By Service Provider
Based on service provider, the market is categorized into contract outsourcing and in-house. In 2022, the contract outsourcing accounted for the highest revenue share due to the advantages of outsourcing, such as risk reduction, resource flexibility, a decrease in initial outlays, and a decline in fixed expenses.
By Product Life Cycle
On the basis of product life cycle, the market is categorized into phase 1, phase 2, phase 3, phase 4, and preclinical. In the global market, the segment accounted for the largest revenue share in 2022 owing to the extensive drug testing on a large patient base, the data gathered and evaluated during this stage.
By Therapeutic Area
Based on therapeutic area, the market is categorized into cardiology, oncology, respiratory systems, neurology, and others. In 2022, the oncology accounted for the highest revenue share due to the rising incidence of cancer.
By Process Flow
Based on process flow, the market is segmented into signal detection, risk management system, and case data management. In 2022, the signal detection segment accounted for the largest revenue share owing to spontaneous reporting systems (SRSs) rely on the primary signal source via which healthcare professionals voluntarily report suspicious cases to other regulatory agencies.
By End Use
In terms of end use, the market is divided into medical device manufacturers, pharmaceuticals, biotechnology companies, and others. In the global market, the pharmaceuticals segment accounted for the largest revenue share in 2022 owing to the fact that the pharma companies outsource the pharmacovigilance process to reduce high upfront costs and fixed operational costs, improve resource flexibility, and obtain extra capacity.
Regional Markets
North America held the largest revenue share in the pharmacovigilance market in 2022, and it is predicted to continue to do so throughout the forecast period. This is attributed to growing spending by key stakeholders on the development of innovative drugs, the growing rate of drug addiction and adverse drug responses is a primary cause of illness and mortality, and the existence of major manufacturers of pharmaceuticals and medical equipment. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing investments and encouraging government programs to satisfy the needs of the populace, rising patient consciousness, the accessibility of different outsourcing companies, and increased output, reduced costs, and sharing of resources.
Competitor Insights
Some of the key players operating in the pharmacovigilance market are Accenture (Ireland), ArisGlobal (US), Capgemini (France), Cognizant (US), FMD K&L (US), IBM Corporation (US), ICON plc. (Ireland), IQVIA (US), ITClinical (Portugal), Laboratory Corporation of America Holdings (US), Linical Accelovance (US), PAREXEL International Corporation (US), TAKE Solutions Ltd. (India), and Wipro Ltd. (India).
This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type, service provider, product life cycle, therapeutic area, process flow, and end use from 2023 to 2033.
Report Scope:
Key Parameters | Details |
---|---|
Market size in 2022 |
|
CAGR |
|
Base Year |
|
Forecast Period |
|
Study Coverage |
|
Qualitative Analysis |
|
Segment Market Scope |
|
Regional Market Scope |
|
Company Profiles |
|
15% Free Customization Available |
|
Segmentation: Pharmacovigilance Market Report 2022 – 2033
Type (Revenue, USD Million), 2022 – 2033
- Intensified ADR Reporting
- Spontaneous Reporting
- EHR Mining
- Cohort Event Monitoring
- Targeted Spontaneous Reporting
Service Provider (Revenue, USD Million), 2022 – 2033
- Contract Outsourcing
- In-house
Product Life Cycle (Revenue, USD Million), 2022 – 2033
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- Phase 4
Therapeutic Area (Revenue, USD Million), 2022 – 2033
- Cardiology
- Oncology
- Respiratory Systems
- Neurology
- Others
Process Flow (Revenue, USD Million), 2022 – 2033
- Signal Detection
- Risk Management System
- Case Data Management
End user (Revenue, USD Million), 2022 – 2033
- Medical Device Manufacturers
- Pharmaceuticals
- Biotechnology Companies
- Others
By Region (Revenue, USD Million), 2022 – 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Table of Contents: Pharmacovigilance Market 2022-2033
- Research Methodology
- Study Objectives
- Study Scope
- Research Framework
- Research Models
- Bottom-up Approach
- Top-down Approach
- Data Triangulation
- Data Analysis
- Data Validation
- Market Size Estimation
- Market Forecast Model
- Research Models
- Introduction: Pharmacovigilance
- Executive Summary
- Market Dynamics
- Market Drivers
- Driver 1
- Driver 2
- Driver 3
- Driver 4
- Driver 5
- Market Restraint
- Restraint 1
- Restraint 2
- Restraint 3
- Restraint 4
- Market Opportunities
- Opportunity 1
- Opportunity 2
- Opportunity 3
- Opportunity 4
- Market Trends
- Trend 1
- Trend 2
- Trend 3
- Trend 4
- Market Challenges
- Challenge 1
- Challenge 2
- Challenge 3
- Challenge 4
- Market Drivers
- Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- Value Chain Analysis
- SWOT Analysis
- Benchmark
- COVID-19 Impact Analysis: Pharmacovigilance Market
- Market Analysis by Type
- Intensified ADR Reporting
- Intensified ADR Reporting Market Forecast, 2022-2033 (USD Million)
- Spontaneous Reporting
- Spontaneous Reporting Market Forecast, 2022-2033 (USD Million)
- EHR Mining
- EHR Mining Market Forecast, 2022-2033 (USD Million)
- Cohort Event Monitoring
- Cohort Event Monitoring Market Forecast, 2022-2033 (USD Million)
- Targeted Spontaneous Reporting
- Targeted Spontaneous Reporting Market Forecast, 2022-2033 (USD Million)
- Intensified ADR Reporting
- Market Analysis by Service Provider
- Contract Outsourcing
- Contract Outsourcing Market Forecast, 2022-2033 (USD Million)
- In-house
- In-house Market Forecast, 2022-2033 (USD Million)
- Contract Outsourcing
- Market Analysis by Product Life Cycle
- Preclinical
- Preclinical Market Forecast, 2022-2033 (USD Million)
- Phase 1
- Phase 1 Market Forecast, 2022-2033 (USD Million)
- Phase 2
- Phase 2 Market Forecast, 2022-2033 (USD Million)
- Phase 3
- Phase 3 Market Forecast, 2022-2033 (USD Million)
- Phase 4
- Phase 4 Market Forecast, 2022-2033 (USD Million)
- Preclinical
- Market Analysis by Therapeutic Area
- Cardiology
- Cardiology Market Forecast, 2022-2033 (USD Million)
- Oncology
- Oncology Market Forecast, 2022-2033 (USD Million)
- Respiratory Systems
- Respiratory Systems Market Forecast, 2022-2033 (USD Million)
- Neurology
- Neurology Market Forecast, 2022-2033 (USD Million)
- Others
- Others Market Forecast, 2022-2033 (USD Million)
- Cardiology
- Market Analysis by Process Flow
- Signal Detection
- Signal Detection Market Forecast, 2022-2033 (USD Million)
- Risk Management System
- Risk Management System Market Forecast, 2022-2033 (USD Million)
- Case Data Management
- Case Data Management Market Forecast, 2022-2033 (USD Million)
- Signal Detection
- Market Analysis by End Use
- Medical Device Manufacturers
- Medical Device Manufacturers Market Forecast, 2022-2033 (USD Million)
- Pharmaceuticals
- Pharmaceuticals Market Forecast, 2022-2033 (USD Million)
- Biotechnology Companies
- Biotechnology Companies Market Forecast, 2022-2033 (USD Million)
- Others
- Others Market Forecast, 2022-2033 (USD Million)
- Medical Device Manufacturers
- Regional Market Analysis
- Regional Market Trends
- North America Pharmacovigilance Market
- North America Pharmacovigilance Market
- North America Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- S. Pharmacovigilance Market
- S. Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Canada Pharmacovigilance Market
- Canada Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast by Process Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Canada Market Size and Forecast, 2022-2033 (USD Million)
- S. Market Size and Forecast, 2022-2033 (USD Million)
- North America Market Size and Forecast, 2022-2033 (USD Million)
- North America Pharmacovigilance Market
- Europe Pharmacovigilance Market
- Europe Pharmacovigilance Market
- Europe Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Germany Pharmacovigilance Market
- Germany Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- UK Pharmacovigilance Market
- UK Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- France Pharmacovigilance Market
- France Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Spain Pharmacovigilance Market
- Spain Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Italy Pharmacovigilance Market
- Italy Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Europe Pharmacovigilance Market
- Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
- Italy Market Size and Forecast, 2022-2033 (USD Million)
- Spain Market Size and Forecast, 2022-2033 (USD Million)
- France Market Size and Forecast, 2022-2033 (USD Million)
- UK Market Size and Forecast, 2022-2033 (USD Million)
- Germany Market Size and Forecast, 2022-2033 (USD Million)
- Europe Market Size and Forecast, 2022-2033 (USD Million)
- Europe Pharmacovigilance Market
- Asia Pacific Pharmacovigilance Market
- Asia Pacific Pharmacovigilance Market
- Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Japan Pharmacovigilance Market
- Japan Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- China Pharmacovigilance Market
- China Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- India Pharmacovigilance Market
- India Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- South Korea Pharmacovigilance Market
- South Korea Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Australia Pharmacovigilance Market
- Australia Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Asia Pacific Pharmacovigilance Market
- Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
- Australia Market Size and Forecast, 2022-2033 (USD Million)
- South Korea Market Size and Forecast, 2022-2033 (USD Million)
- India Market Size and Forecast, 2022-2033 (USD Million)
- China Market Size and Forecast, 2022-2033 (USD Million)
- Japan Market Size and Forecast, 2022-2033 (USD Million)
- Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
- Asia Pacific Pharmacovigilance Market
- Latin America Pharmacovigilance Market
- Latin America Pharmacovigilance Market
- Latin America Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Brazil Pharmacovigilance Market
- Brazil Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Mexico Pharmacovigilance Market
- Mexico Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Argentina Pharmacovigilance Market
- Argentina Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Latin America Pharmacovigilance Market
- Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
- Argentina Market Size and Forecast, 2022-2033 (USD Million)
- Mexico Market Size and Forecast, 2022-2033 (USD Million)
- Brazil Market Size and Forecast, 2022-2033 (USD Million)
- Latin America Market Size and Forecast, 2022-2033 (USD Million)
- Latin America Pharmacovigilance Market
- MEA Pharmacovigilance Market
- MEA Pharmacovigilance Market
- MEA Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- GCC Pharmacovigilance Market
- GCC Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- South Africa Pharmacovigilance Market
- South Africa Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of MEA Pharmacovigilance Market
- Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
- Market Size and Forecast by Type, 2022-2033 (USD Million)
- Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
- Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
- Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
- Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
- Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
- Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
- South Africa Market Size and Forecast, 2022-2033 (USD Million)
- GCC Market Size and Forecast, 2022-2033 (USD Million)
- MEA Market Size and Forecast, 2022-2033 (USD Million)
- MEA Pharmacovigilance Market
- Competitor Analysis
- Market Share Analysis, 2021 & 2029
- Major Recent Developments
- Company Profiles
10.1. Accenture (Ireland)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- ArisGlobal (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Capgemini (France)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Cognizant (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- FMD K&L (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- IBM Corporation (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- ICON plc. (Ireland)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- IQVIA (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- ITClinical (Portugal)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Laboratory Corporation of America Holdings (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Linical Accelovance (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- PAREXEL International Corporation (US)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- TAKE Solutions Ltd. (India)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Wipro Ltd. (India)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company 15
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Others Prominent Players
- Conclusion & Recommendations